- Record: found
- Abstract: found
- Article: not found
Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden.
Bengt Nilsson
1 ,
Per Bümming ,
Jeanne M Meis-Kindblom ,
Anders Odén ,
Aydin Dortok ,
Bengt Gustavsson ,
Katarzyna Sablinska ,
Lars-Gunnar Kindblom
Feb 15 2005
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Recent breakthroughs regarding gastrointestinal stromal tumors (GIST) and their pathogenesis have redefined diagnostic criteria and have led to the development of molecularly targeted drug therapy. New treatment options mandate more accurate information regarding the incidence, prevalence, clinical behavior, and prognostic factors of GIST.